Relmada Therapeutics Inc. (RLMD)
Relmada Therapeutics Max Pain By Strike
RLMD trades at $0.63, 26.0% above the near-term max pain of $0.5 expiring Sep 19, 2025 (33 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$7.5), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Relmada Therapeutics Max Pain By Expiry
Max pain for RLMD shows a downward trend from 7.5 to 0.5, indicating bearish sentiment or hedging activity. The 304% spread signals divergent expectations across timeframes. Levels distributed around 0.63. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 0.5 | -0.13 (-21.16%) |
| Oct 17, 2025 | 2.5 | 1.87 (294.20%) |
| Nov 21, 2025 | 0.5 | -0.13 (-21.16%) |
| Feb 20, 2026 | 0.5 | -0.13 (-21.16%) |
| Dec 18, 2026 | 7.5 | 6.87 (1082.59%) |